综述

Myonectin在心血管疾病和代谢性疾病中的研究进展

展开
  • (广东省人民医院赣州医院(赣州市立医院)心血管内科,赣州 341009)
△ gypeifang@163.com

收稿日期: 2024-07-31

  修回日期: 2024-08-06

  录用日期: 2024-08-08

  网络出版日期: 2024-12-25

基金资助

* 国家自然科学基金(82360089);江西省自然科学基金重点项目(20232ACB206002)资助课题

Research Progress of Myonectin in Cardiovascular and Metabolic Diseases

Expand
  • (Department of Cardiology, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou 341099, China)
△ gypeifang@163.com

Received date: 2024-07-31

  Revised date: 2024-08-06

  Accepted date: 2024-08-08

  Online published: 2024-12-25

摘要

肌肉因子对心血管疾病和代谢性疾病具有显著的改善作用。肌联素(myonectin)是新近发现的肌肉因子,与多种心血管疾病和代谢性疾病如冠心病、糖尿病、肥胖等密切相关。本文围绕myonectin的生物学特性、其在心血管疾病和代谢性疾病发生发展中的作用及可能的作用机制进行综述,以期为心血管疾病和代谢性疾病的防治提供新的靶点和策略。

本文引用格式

谢 正, 裴 芳△ . Myonectin在心血管疾病和代谢性疾病中的研究进展[J]. 生理科学进展, 2024 , 55(6) : 523 -529 . DOI: 10.20059/j.cnki.pps.2024.10.1131

Abstract

Myokines exert a significant beneficial effect on cardiovascular and metabolic diseases. As a recently identified myokine, myonectin is closely associated with various cardiovascular and metabolic diseases, such as coronary heart disease, diabetes, and obesity. This article reviews the biological characteristics of myonectin, its role in the occurrence and development of cardiovascular and metabolic diseases, and its potential mechanisms of action, aiming to provide new targets and strategies for the prevention and treatment of cardiovascular and metabolic diseases.
Options
文章导航

/